Cell-based product classification procedure: What can be done differently to improve decisions on borderline products?

Highlights • Classification of a product as ATMP, transplant or blood component may be challenging. • CAT is usually approached for advice on classification of borderline products. • Product classification has major organizational, economic and regulatory implications. • CAT's criteria to classify cell products can impact accessibility and sustainability. • Product classification may benefit from more interaction among competent authorities.